The dynamic interplay between kinases and substrates is crucial for the formation of catalytically committed complexes that enable phosphoryl transfer. However, a clear understanding on how substrates modulate kinase structural dynamics to control catalytic efficiency is still missing. Here, we used solution NMR spectroscopy to study the conformational dynamics of two complexes of the catalytic subunit of the cAMP-dependent protein kinase A with WT and R14 deletion phospholamban, a lethal human mutant linked to familial dilated cardiomyopathy. Phospholamban is a central regulator of heart muscle contractility, and its phosphorylation by protein kinase A constitutes a primary response to β-adrenergic stimulation. We found that the single deletion of arginine in phospholamban's recognition sequence for the kinase reduces its binding affinity and dramatically reduces phosphorylation kinetics. Structurally, the mutant prevents the enzyme from adopting conformations and motions committed for catalysis, with concomitant reduction in catalytic efficiency. Overall, these results underscore the importance of a welltuned structural and dynamic interplay between the kinase and its substrates to achieve physiological phosphorylation levels for proper Ca 2+ signaling and normal cardiac function.
The dynamic interplay between kinases and substrates is crucial for the formation of catalytically committed complexes that enable phosphoryl transfer. However, a clear understanding on how substrates modulate kinase structural dynamics to control catalytic efficiency is still missing. Here, we used solution NMR spectroscopy to study the conformational dynamics of two complexes of the catalytic subunit of the cAMP-dependent protein kinase A with WT and R14 deletion phospholamban, a lethal human mutant linked to familial dilated cardiomyopathy. Phospholamban is a central regulator of heart muscle contractility, and its phosphorylation by protein kinase A constitutes a primary response to β-adrenergic stimulation. We found that the single deletion of arginine in phospholamban's recognition sequence for the kinase reduces its binding affinity and dramatically reduces phosphorylation kinetics. Structurally, the mutant prevents the enzyme from adopting conformations and motions committed for catalysis, with concomitant reduction in catalytic efficiency. Overall, these results underscore the importance of a welltuned structural and dynamic interplay between the kinase and its substrates to achieve physiological phosphorylation levels for proper Ca 2+ signaling and normal cardiac function.
phospholamban | phosphorylation | conformational dynamics | NMR | calcium regulation P hosphorylation by cAMP-dependent protein kinase A (PKA) is a central signaling pathway in cardiomyocytes, where it modulates the activity of several Ca 2+ handling proteins (1, 2) . In particular, PKA targets phospholamban (PLN), a small membrane protein embedded in the sarcoplasmic reticulum that binds and regulates the activity of the sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA). The SERCA/PLN complex plays a critical role in cardiac contractility, because it is responsible for Ca 2+ reuptake in the sarcoplasmic reticulum, thereby controlling muscle relaxation, or diastole (1) . PLN regulation of SERCA keeps Ca 2+ flux within a physiological window (3) . Unphosphorylated PLN reduces SERCA's apparent affinity for Ca 2+ , whereas phosphorylation at Ser16 reverses PLN's inhibitory effect, increasing Ca 2+ flux and enhancing cardiac muscle relaxation (4) . PKA phosphorylation of PLN is a primary response to β-adrenergic stimulation in the heart, affecting cardiac output directly (5) . Altered levels of PLN phosphorylation (i.e., hypo-or hyperphosphorylation) cause SERCA's function to be outside this physiological window. Specifically, aberrant PLN phosphorylation depresses Ca 2+ cycling, with an attenuation of Ca 2+ transients in both amplitude and frequency, resulting in cardiac disease (6, 7) . Six naturally occurring mutations of PLN have been linked to early and/or late onset dilated cardiomyopathy (DCM), a leading cause of morbidity and mortality worldwide (8, 9) . First reported by Kranias et al. (10, 11) , the R14del mutation of PLN (PLN R14del ) was found in several DCM patients (10) and was more recently identified in 14% of a cohort of 354 patients diagnosed with either DCM or arrhythmogenic right ventricular cardiomyopathy (12) . It has been proposed that the dysfunctional effects of PLN R14del are due to chronic suppression of SERCA activity, with a synergistic inhibition by the mutant and the WT PLN (PLN WT ) (10, 13) . Recent studies, however, show that PLN phosphorylation by PKA-C is significantly hindered in R14del transgenic mice (∼7% of WT levels), causing Ca 2+ mishandling and progression of DCM (13) . Although the phenotype and genotype of the R14 deletion have been identified, the molecular mechanisms for its aberrant phosphorylation are still unknown.
The R14 deletion is located at the recognition sequence for the catalytic subunit of PKA (PKA-C) ( Fig. 1) (10) . From the X-ray structure of the PKA-C/ATPγN/PLN WT complex [Protein Data Bank (PDB) ID code 3O7L], the PLN consensus sequence for PKA-C (R-R-X 1 -S-X 2 , where X denotes a variable amino acid) adopts an extended conformation within the binding groove (14, 15) . The side chain of R14 (P-2 site) points toward the large lobe and interacts with Y204, E230, and E203, whereas the side chain of R13 (P-3 site) interacts with S51, the ribose ring, and hydroxyl group of Y330, clamping on the small lobe ( Fig. 1 A and B) (14) . Based on these structural features, we hypothesized that the R14 deletion disrupts intermolecular interactions between enzyme and substrate, affecting the motions responsible for opening and closing the active cleft and ultimately enzyme turnover. To test this hypothesis, we compared the kinetics of phosphorylation, thermodynamics of binding, and enzyme structural dynamics of the PKA-C/PLN R14del complex to
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The authors declare no conflict of interest. Tables S1 and S3 ) (14, 16, 17) . We found that PKA-C exhibits high substrate affinity for PLN Fig. 2A) . On a fourfold increase in PKA-C concentration (from 64 to 256 nM total enzyme) and an increase in substrate from 100 to 900 μM, we observed only marginal phosphorylation (SI Appendix, Fig. S1 B and C). Under these experimental conditions, the k cat is ∼6 times smaller and the catalytic efficiency is ∼300 times lower for PLN Table S1 ). Moreover, we repeated phosphorylation assays using full-length PLN WT and PLN R14del . On incubation with PKA-C, we detected complete phosphorylation of PLN WT (five phosphates per pentamer; Fig. 2C ). In contrast, PLN R14del was only partially phosphorylated, as shown by the slight band shift in the SDS/PAGE (Fig. 2C ). These phosphorylation assays exclude any effect of the transmembrane domains and confirm the sluggish phosphorylation kinetics measured for PLN These data are in agreement with phosphorylation kinetics carried out with model peptides missing the P-3 site (19) and PLN (20, 21) . (14) shows that the arginine residue in P-3 position of PLN forms an electrostatic network with E127, Y330, and the ribose moiety of ATP (Fig. 1B) , whereas the P-2 arginine interacts with R133, E230, and Y204. This dense network of interactions positions the substrate in a catalytically committed conformation. We reasoned that the removal of one of the two arginine residues in the recognition sequence may alter the enzyme conformation and motions. To test this hypothesis, we analyzed the conformational dynamics of the complexes using solution NMR spectroscopy. Specifically, we used the [ Tables S2, S6 , and S7), indicating that the overall conformational dynamics of the complexes on the fast timescale are similar. However, significant local variations of HX-NOE values were found between the two complexes. Residues neighboring the Mg 2+ positioning, catalytic loop, the αF-αG loop, and the αG-αH loop (D161, R190, V191, D241, Q242, G253, K254, and R256), linked to be involved in substrate binding and regulation (26) , are more flexible when PKA-C is bound to PLN R14del 1−19 , whereas several residues flanking the C-helix, the αA-β1 linker, and the C terminus (S34, Q35, T37, K83, Q96, A97, F347, T348, E349, F350) appear to be more rigid. These changes in the fast dynamic timescale might be related to the changes in the overall binding entropy as measured by ITC (27) .
Moreover, we investigated conformational dynamics in the microsecond/millisecond timescale by quantifying the contribution of chemical exchange to the transverse relaxation rate (R ex ) using the TROSY Hahn-Echo experiment (28) . We found striking differences in the R ex values for the two complexes (SI Appendix, Tables S2 and S8-S10). In agreement with the previously reported data, the binary form of the enzyme with ATPγN experiences considerable conformational dynamics (14) (SI Appendix, Fig. S9 ), especially along catalytic structural elements such as the glycine rich loop, C-helix, peptide positioning loop, and DFG loop (26) . When PLN and S10). In addition, we observed a substantial increase in conformational dynamics in the microsecond/millisecond timescale in several other regions. Specifically, due to the loss of the P-3 arginine, the acidic patch region positioned along the C-terminal tail (residues 330-334) is no longer electrostatically connected to the active site and experiences an increase in conformational dynamics (Fig. 4) . Increased motions occur for residues around D220, which is the conduit for allosteric signaling from the F-helix to the regulatory spine (R-spine; Fig. 4 To interpret the dynamic effects of the deletion of P-3 arginine in the substrate, we performed atomistic MD simulations in explicit environments on both PKA-C/PLN (Fig. 1B) (14, 26) . In particular, the acidic cluster surrounding Y330 latches on the small lobe, clamping the glycine-rich loop down into the active site. Also, E127 in the linker region connects the small and large lobes. In contrast, the P-2 arginine points toward the large lobe, interacting with E203, Y204, and E230. These electrostatic interactions are part of an allosteric network that ensures structural and dynamic communication within the enzyme (16, 24, 30) (Fig. 5A) . During ∼100 ns of MD simulations of the PKA-C/ PLN WT 1−19 complex, we found that the P-2 arginine residue (R14) does not change its side chain conformation, thus preserving the interresidue interactions present in the crystal structure ( Fig. 5A and SI Appendix, Fig. S12 ). In contrast, the electrostatic interaction between the R13 guanidino group (P-3 site) and the hydroxyl group of Y330 breaks apart, with an ∼90°rotation of the Arg side chain torsion angles (Fig. 5A) . The latter causes the formation of new transient interactions between the guanidino group and the α and β phosphates of ATP (17) (SI Appendix, Fig. S12 ), with the P-3 Arg (R13) acting as a three-way switch between the small lobe, large lobe, and the ATP molecule. With the PKA-C/PLN R14del 1−19 complex, the transient interactions between the guanidine group, Y330, and the phosphates of ATP are lost, pushing the P-3 side chain away from the active site (Fig. 5B) . The opening and closing motions of the enzyme on binding the WT and mutated substrate were analyzed using principle component analysis (PCA ; Fig. 5C ). Fig. S12 ). The analysis demonstrates that the glycine rich, αF-αG, and the αG-αH loops become more dynamic with the mutation, whereas the αA-β1 linker and the C terminus becomes more rigid. This analysis corroborates the HX-NOE data, and, taken together, these results suggest that the missing P-3 guanidino group changes the interactions in the vicinity of the active site, affecting the opening and closing of the kinase.
) (16).

MD Simulation of the Ternary Complexes with PLN
Discussion
The R14 deletion mutant of PLN provides a unique opportunity to study the effects of dysfunctional substrates on kinase structural dynamics using NMR spectroscopy. In fact, structural studies on complexes between kinases and their substrates are rather sparse, because the low binding affinity prevents crystallization. As a result, most X-ray structures are obtained in the presence of small drugs or pseudosubstrate inhibitors (31) . The R14 deletion is located within the kinase recognition site and eliminates the P-3 site. The P-3 site is crucial for efficient kinetics as assessed in model peptide substrates (19) . In fact, the missing electrostatic interactions at the P-3 arginine changes the register of the recognition sequence, with Arg-9 shifted to the P-6 position (Fig. 1) . These structural changes hinder PLN R14del 1−19 binding to PKA-C. However, a reduction in affinity alone is insufficient to explain the sluggish kinetics as most kinase/substrate interactions are weak in nature (31) . For instance, the standard PKA-C substrate Kemptide has a K d of ∼200 μM, yet it displays kinetic parameters common to other PKA-C substrates (16, 30, 32) . Although the R14 does not actively participate in the phosphorylation reaction (33) , the removal of R14 in PLN has a dramatic effect on the enzyme. Not only does it reduce PLN's binding affinity, it also affects the organization of the active site. In fact, in the complex with the WT, R13 and R14 act as 
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Y204 Y204 P-site P-site P P γ γ P P β β P P α α 0 0 l l i I te e N-t N-t N-t te e te e te a bridgehead between the small lobe (through R13/Y330) and large lobe (R13/E127 and R14/E203/Y204). The guanidino group of R13 interacts with the γ-phosphate of ATP, likely facilitating the opening and closing of the active site. Although the guanidino group of the R14 arginine residue is firmly anchored to the large lobe (Fig. 5A) , the R13 arginine is more dynamic and establishes transient interactions with the acidic cluster of PKA-C (328-334), a key region for determining opening and closing of the active cleft (26) . The role of these interactions in catalysis is also supported by steady-state phosphorylation kinetic measurements, which show that the PKA-C Y330F mutant decreased k cat by approximately 60% and increased K M for Kemptide approximately fivefold (34) . The dramatic loss of catalytic efficiency for PLN R14del 1−19 compared with Y330F indicates the loss of P-3 site in PLN is more disruptive than simply the loss of an electrostatic bridge. In addition to a perturbation of the structural and electrostatic preorganization at the active site, the deletion of R14 disrupts the anchoring of the substrate with the small lobe, enhancing the conformational dynamics across the enzyme backbone (Fig. 4 and SI Appendix, Figs. S7 and S8) . With completion of the backbone resonance assignment on the three major structural forms of PKA-C (apo, binary, and closed; Fig. 4 and SI Appendix, Fig. S3 ), we were able to identify several resonances that were previously unassigned and were observable with the addition of PLN . This allowed us to identify that PKA-C bound to substrate remains dynamic, but attenuated with respect to the nucleotide bound form, reflecting an opening and closing of the enzyme (committed conformational dynamics) (14, 17) . In contrast, the elimination of the interactions at the P-3 site in the PKA-C/PLN R14del 1−19 complex prevents the assembly of the small and large lobes, and the complex adopts a partially closed conformation with dysfunctional dynamics (Fig. 6) .
Recently, we showed that the allosteric mutant of PKA-C, Y204A (35) , disrupts the hydrophobic core adjacent to the active site and removes electrostatic interactions with the P-2 arginine, desynchronizing the opening and closing motions globally. The deletion of the P-3 arginine increases the conformational dynamics extending throughout the N terminus (αC-β1-linker), the C-terminal tail (acid patch) (26) , and the F-helix, which constitute the central signaling conduit of the kinase connecting the R-spine with the F-helix (36) (Fig. 4 and SI Appendix, Figs. S7 and S8). Although the lack of allosteric transmission from the active site to the C-terminal tail could be anticipated by the loss of the P-3 electrostatic interaction in the active site, the behavior of the conformational dynamics displayed by the central signaling conduit was unexpected.
Therefore, this lethal mutation, along with a partial closing of the active cleft and dysfunctional motions, alters the allosteric network with concomitant decrease of the catalytic efficiency (14, 17) .
Case studies on dihydrofolate reductase using artificial mutations have predicted that dysfunctional dynamics (37) or a dynamic KO (38, 39) dramatically reduce enzymatic activity and have been exemplified in other systems as well (40) (41) (42) (43) (44) (45) . These studies have overlooked the contribution that substrates have on promoting productive motions. The natural occurring R14 deletion in the PKA-C recognition sequence of PLN is a unique example that advocates for a central role of the substrate in the organization of the active site and to promote productive conformational fluctuations. Although these motions might not play a direct role in the chemical step (46) (i.e., phosphoryl transfer), they dictate the opening and closing of the active cleft for phosphoryl transfer and affect the overall catalytic efficiency that can lead to DCM.
Absent or reduced PLN phosphorylation levels cause SERCA to be constitutively down-regulated, leading to reduced Ca 2+ uptake in the SR lumen and, ultimately, heart disease (6, 7). Recent in vitro studies demonstrated that several hereditary mutants of PLN constitute a poor substrate for PKA-C (20, 47) . Specifically, hypophosphorylation of PLN has been detected for the PLN R9C mutant, where a cysteine substitution occurs at the P-7 site (47), as well as for PLN R14del . However, the molecular etiologies for these mutants' lack of phosphorylation are dissimilar (21, 48) . Although reduced phosphorylation of PLN R9C has been attributed to disulfide bond formation between adjacent monomers in the pentamers, rendering the phosphorylation site inaccessible to PKA-C (47), R14 deletion prevents the formation of the catalytically committed conformation. Nonetheless, in both cases, slow phosphorylation kinetics reduce calcium uptake with concomitant decline of cardiac output, leading to heart failure. Importantly, the fight or flight mechanism, which results in increased PKA-C activity and decreased SERCA inhibition, is severely impaired by the slow phosphorylation of PLN R14del 1−19 , affecting Ca 2+ transients and leading to DCM (10, 13). Our findings emphasize the importance of functional dynamics between the enzyme and substrate to achieve physiological phosphorylation levels for normal cardiac function. These results elucidate a pathway by which dysfunctional conformational dynamics of proteins may result in pathological phenotypes, giving new and exciting evidence of a structural basis of DCM linked to this specific pathway.
Materials and Methods
Sample Preparation. Recombinant catalytic subunit of PKA was expressed in BL21 DE3 cells by the method described by Studier at 24°C (49), and N PKA-C was expressed as previously described (16) . Purification of PKA-C was performed as previously described using the His 6 -RIIα(R213K) subunit (50) , and a second purification step was performed by using the HiTrap SP cation exchange column. Peptides (PLN were prepared in 20 mM MOPS, 90 mM KCl, 10 mM DTT, 10 mM MgCl 2 , and 1 mM NaN 3 at pH 6.5. For nucleotide saturation, 2 mM of ATPγN was added. All experiments were performed in 300 K. Data were fit to the Wiseman Isotherm (51) assuming onesite binding using the NanoAnalyze (TA instruments) software. Further details are provided in SI Appendix, SI Materials and Methods.
Enzyme Assays. The steady-state activity assays of PLN [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] and R14del [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] under saturating ATP concentrations were performed spectrophotometrically at 298 K as described by Cook et al. (52) . The values of V max and K m were obtained from a nonlinear fit of the initial velocities to the Michaelis-Menten equation. The extent of phosphorylation for full-length PLN analogs was monitored by gelshift assays using 10 μM of substrate (assessed by densitometry), 1,000 U/mg PKA-C in 0.1% octyl-glucoside, 20 mM MOPS (pH 7.25), 0.05 mM PMSF, 0.02% NaN 3 , and 1 mM MgCl 2 . The reaction was initiated by adding 1 mM ATP and was incubated for 12 h at 30°C. The phosphorylation reaction was then stopped by addition of 1% SDS. Tris-tricine polyacrylamide gels (12%) were run with 2 μg of PLN (∼5-μL reaction mixture) and stained with Coomassie brilliant blue.
NMR Measurements. Standard TROSY-select triple resonance, steady-state NOE and HSQC experiments were carried out on an 850-MHz Bruker Advance III spectrometer equipped with a TCI cryoprobe. Concentrations of samples for triple resonance experiments were ∼0.4-0.7 mM, and samples for relaxation experiments were 0.25-0.4 mM; 12 mM of ATPγN was added for the nucleotide-bound form and 1.0-2.0 mM of peptide (PLN WT 1−19 /PLN R14del 1−19 ) for the ternary complex. Spectra were collected at 300 K, processed using NMRPipe (53) , and visualized using Sparky. R ex values were measured using the TROSY Hahn-Echo pulse sequence (28) and analyzed as described previously (17, 54) . Qualitative verification of R ex was done by measuring inverse peak heights as previously described (54) . Further details are provided in SI Appendix, SI Materials and Methods.
MD Simulations. MD simulations were set up using CHARMMc36 and run with the software NAMD (nanoscale molecular dynamics) using an initial docked structure as described in SI Appendix, SI Materials and Methods. All structures were solvated in a TIP3 water box with K + and Cl− added as counter ions to reach an ionic strength of ∼150 mM. Following an initial equilibration, 80 ns of MD simulations of PKA-C/PLN R14del 1−19 were performed at constant temperature and pressure. PCA and RMSF analyses were performed as previously described (17) . Further details are provided in SI Appendix, SI Materials and Methods.
